Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
melanoma
Biotech
Have mRNA cancer vaccines arrived? Biopharma execs weigh in
Executives from BMS, Regeneron, Roche's Genentech and more weighed in on the future of cancer vaccines after recent positive readouts.
Angus Liu
Jan 25, 2023 10:30am
Moderna, Merck & Co. cancer vaccine slashes melanoma recurrence
Dec 13, 2022 8:25am
Erasca slides a Novartis melanoma med into pipeline for $20M
Dec 9, 2022 10:50am
Instil Bio takes the ax to its lead asset, cuts 60% of its staff
Dec 8, 2022 10:24am
Making melanoma cells immortal comes down to gene mutation synergies
Nov 10, 2022 2:00pm
Merck ditches Cavatak more than 4 years after buying Viralytics
Oct 27, 2022 10:40am